Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
4.37
-0.05 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
4.41
0.92%
After-hours: Aug 15, 2025, 07:05 PM EDT
Cellectar Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.52 | -16.5 | -43.87 | -43.05 | -745.13 | -39.98 | -51.9 | -16.31 | -20.03 | -14.28 | -16.68 | -19.72 | -24.66 | -51.5 | -50.07 | -71.76 | -78.12 | -91.44 |
PEG Ratio | -0.00 | -0.11 | 0.51 | -0.37 | 10.03 | -0.52 | 0.79 | -0.25 | 7.51 | 5.50 | 0.42 | -4.01 | -1.12 | -50.99 | -24.29 | 4.81 | 5.73 | 1.84 |
PS Ratio | n/a | n/a | 1.34K | n/a | n/a | n/a | 4.68K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.88 | 52.82 | 28.92 | 166.53 | 221.32 | 131.89 | -1.14K | 196.11 | -1.41K | 65.87 | 31.05 | 48.30 | 36.31 | 46.48 | 35.87 | 43.29 | 42.83 | 46.71 |
P/FCF Ratio | 1.04 | -46.46K | -37.66 | -275.49 | -193.48 | -257.87 | -156.81 | -103.36 | -87.49 | -67.25 | -63.94 | -87.73 | -125.8 | -249.47 | -255.43 | -259.64 | -273.64 | -489.23 |
P/OCF Ratio | 1.05 | -46.46K | -37.87 | -275.49 | -193.78 | -258.29 | -161.16 | -111.01 | -87.49 | -67.25 | -64.96 | -87.82 | -127.35 | -250.96 | -262.78 | -259.81 | -273.94 | -489.23 |
OCF/S Ratio | n/a | n/a | -35.32 | n/a | n/a | n/a | -29.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.07 | 0.06 | 0.03 | 0.03 | 0.04 | 0.02 | -0.41 | 0.12 | -1.25 | 0.08 | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 2.15 | 2.47 | 2.58 | 1.77 | 1.84 | 2.54 | 0.81 | 1.22 | 0.87 | 1.99 | 3.71 | 2.88 | 4.51 | 6.75 | 9.16 | 13.07 | 13.39 | 10.84 |
Current Ratio | 2.15 | 2.47 | 2.58 | 1.77 | 1.84 | 2.54 | 0.81 | 1.22 | 0.87 | 1.99 | 3.71 | 2.88 | 4.51 | 6.75 | 9.16 | 13.07 | 13.39 | 10.84 |
Asset Turnover | n/a | n/a | 0.01 | n/a | n/a | n/a | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.9 | -0.8 | -0.16 | -0.97 | -0.07 | -0.82 | 5.49 | -3.01 | 17.60 | -1.15 | -0.47 | -0.61 | -0.37 | -0.23 | -0.18 | -0.15 | -0.14 | -0.13 |
Return on Assets | -0.4 | -0.41 | -0.09 | -0.39 | -0.03 | -0.5 | -0.62 | -0.64 | -1.26 | -0.57 | -0.33 | -0.4 | -0.29 | -0.19 | -0.16 | -0.14 | -0.13 | -0.12 |
Return on Invested Capital | -0.76 | -0.63 | -0.81 | -0.78 | -0.95 | -0.45 | 16.73 | -1.81 | -48.47 | -1.07 | -0.46 | -0.6 | -0.36 | -0.22 | -0.18 | -0.15 | -0.14 | -0.13 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.79 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -7.62 | n/a | n/a | n/a | -22.55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -7.41 | n/a | n/a | n/a | -22.73 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -41.24 | n/a | n/a | n/a | -37.98 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -41.02 | n/a | n/a | n/a | -37.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |